Electrophysiological actions and pharmacological evaluation of anti-arrhythmic drugs
Chen Xiu
Yao Xue Xue Bao 14(2): 120-128
1979
ISSN/ISBN: 0513-4870 PMID: 388979 Document Number: 148437
Document emailed within 1 workday
Related Documents
Jacovella, G.; Vajola, F.S.; Floris, B.; Citone, C.; Pace, F.; Milazzotto, F. 1975: Electrophysiological effects of anti-arrhythmic calcium-antagonistic drugs in patients with conduction disorders: preliminary observations on verapamil Bollettino Della Societa Italiana di Cardiologia 20(12): 1645-1651Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Allen, J.D.; Ekue, J.M.; Pantridge, J.F.; Shanks, R.G.; Zaidi, S.A. 1971: Experimental cardiac arrhythmias in the evaluation of anti-arrhythmic drugs British Journal of Anaesthesia 43(7): 720-721
Randrup, A.; Mogilnicka, E. 1976: Spectrum of pharmacological actions on brain dopamine. Indications for development of new psychoactive drugs. Discussion of amantadines as examples of new drugs with special actions on dopamine systems Polish Journal of Pharmacology and Pharmacy 28(6): 551-556
Krishnarao, K.; Achari, G. 1972: Anti-arrhythmic actions of two newer antihistaminics Journal of the Indian Medical Association 58(1): 1-4
Mashiba, H.; Kanaya, S. 1974: Actions of anti-arrhythmic agents on physiology of myocardial cell membrane Nihon Rinsho. Japanese Journal of Clinical Medicine 32(9): 2829-2834
Beck, O.A.; Spielmann, H.; Witt, E.; Oeff, M.; Liddard, C.; Hochrein, H. 1980: Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research Arzneimittel-Forschung 30(12): 2172-2181
Touboul, P. 1993: Non-pharmacological treatment of ventricular tachycardia (anti-arrhythmic surgery excluded) Archives des Maladies du Coeur et des Vaisseaux 86(5 Suppl): 809-817
Platek, H. 1973: Anti-arrhythmic drugs Wiadomosci Lekarskie 26(7): 623-627
Weiss-Simon, C.; Spangenberg, G.; Michel, D. 1980: Anti-arrhythmic agents. 2. Special anti-arrhythmic effect, known drug interactions Fortschritte der Medizin 98(15): 569-572
De Micheli, A. 1987: Development of anti-arrhythmic drugs Archivos del Instituto de Cardiologia de Mexico 57(1): 1-8
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Chung, E.K. 1973: The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction Singapore Medical Journal 14(3): 205-210
Matta, F.; De Marchi, M.; Pecchio, F.; Bevilacqua, R.; Aillon, A.; Piccinino, C.; Riva, L.; Alvino, A.; Angelino, P.F. 1981: Clinical significance of the determination of lidocaine and anti-arrhythmic drugs in acute myocardial infarct Minerva Cardioangiologica 29(4): 131-136
Libersa, C.; Caron, J.; Guedon-Moreau, L.; Lacroix, D. 1992: Pro-arrhythmic effects of anti-arrhythmic agents. Study methods and difficulties in analysis Therapie 47(5): 363-365
Nozaki, A.; Sugimoto, T. 1985: Evaluation of anti-arrhythmic drug efficacy Nihon Rinsho. Japanese Journal of Clinical Medicine 43(11): 2411-2416
Fujita, T.; Miyazaki, M. 1972: Clinical evaluation of beta-receptor blockers in anesthesia. 4. Anti-arrhythmic effects of Y-6124 Masui. Japanese Journal of Anesthesiology 21(5): 450-457
Lotto, A.; Finzi, A. 1986: Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification Giornale Italiano di Cardiologia 16(4): 333-335
Ochotny, R.; Lowicki, Z. 1985: Pharmacokinetics and preliminary evaluation of the anti-arrhythmic effectiveness of N-acetylprocainamide in ventricular disorders of cardiac rhythm Polski Tygodnik Lekarski 40(51-52): 1445-1447
Paparella, N.; Pirani, R.; Cappato, R.; Candini, G.C.; Alboni, P. 1986: Method for differentiating in humans the direct effects of anti-arrhythmic drugs from those mediated by the autonomic nervous system. Effects of quinidine and propafenone Giornale Italiano di Cardiologia 16(9): 762-769